A partnership between Children’s Hospital and the venture-capital firm Osage University Partners (OUP) will expand the opportunities to commercialize the research done at Children’s Hospital.
Sickle cell disease affects millions of people worldwide and is the most common inherited disorder in African Americans, of whom 1 in 375 is born with the disease.
The Center for Injury Research and Prevention (CIRP) recently shared the amazing story of a student who swam across the English Channel to benefit CHOP’s Violence Intervention Program (VIP).
Kids who survive cancer may face a variety of physical and emotional challenges as a result of their treatment. One of these is the possibility of infertility following cancer treatment.
The groundbreaking immune therapy work being done by The Children’s of Hospital of Philadelphia’s Stephen M. Grupp, MD, PhD, was recently highlighted on Australia’s 60 Minutes.
Concerns about the impact of the sequestration on science have been gaining momentum in recent weeks.
Sleep experts have conducted the first multicenter clinical trial of obstructive sleep apnea in children and have found that those who underwent surgery to remove their adenoids and tonsils had notable improvements.
Proton therapy, which uses high-energy subatomic particles, may offer a precise, organ-sparing treatment option for children with high-risk forms of neuroblastoma, the most common solid tumor of early childhood.
Children’s Hospital investigators may have developed a completely new type of cancer immunotherapy, one that involves harnessing the body’s immune system to attack tumors.
A neonatologist at CHOP led a new study showing current non-invasive techniques for respiratory support are less effective than previously thought in reducing severe lung injury in very premature infants.